JupiteX Get the app
Health & Medicine21 Nov 2026 · about 6 min

India gives 10 million HPV vaccine doses, covers 87% of target girls in nine months, health ministry

The brief

India’s National HPV Vaccination Campaign passed a major milestone: more than 10 million doses were given in its first nine months. The health ministry reported that this covered nearly 87% of the identified target group. The drive matters because HPV infections can cause cervical cancer, a significant health concern for women in India. Launched in February 2026 by Prime Minister Narendra Modi, the campaign offers a free, voluntary, single-dose HPV vaccine to 14-year-old girls at government health facilities. Vaccination requires parental consent. The ministry credits coordination among states, Union Territories, health workers, teachers, parents and local communities for expanding access. Coverage varied by state. Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar each reached 100% of their identified target populations. Uttar Pradesh had the highest number of girls vaccinated, at least 29.33 lakh. The campaign uses the U-WIN digital platform to track beneficiaries and monitor progress in real time.

01

What milestone did India’s HPV vaccination campaign reach in its first nine months?

India’s National HPV Vaccination Campaign passed a major milestone: more than 10 million doses were given in its first nine months. The health ministry reported that this covered nearly 87% of the identified target group. The drive matters because HPV infections can cause cervical cancer, a significant health concern for women in India.

Launched in February 2026 by Prime Minister Narendra Modi, the campaign offers a free, voluntary, single-dose HPV vaccine to 14-year-old girls at government health facilities. Vaccination requires parental consent. The ministry credits coordination among states, Union Territories, health workers, teachers, parents and local communities for expanding access.

Coverage varied by state. Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar each reached 100% of their identified target populations. Uttar Pradesh had the highest number of girls vaccinated, at least 29.33 lakh. The campaign uses the U-WIN digital platform to track beneficiaries and monitor progress in real time.

02

How do 10 million doses compare with the campaign’s target of about 12 million girls, and what does 87% coverage mean?

The campaign’s target cohort is approximately 12 million girls, based on Registrar General of India 2021 population estimates. In nine months, India administered more than 10 million doses. The ministry described this as nearly 87% cumulative coverage, a measure of how much of the identified target group has been reached.

The figures are rounded: “more than 10 million” is not an exact dose count, and the target is also approximate. So the reported 87% is the ministry’s coverage figure, not a calculation that can be reproduced exactly from the rounded numbers alone. The campaign provides one dose to each eligible girl.

Coverage is not the same as the percentage of all girls in India or all women protected from cervical cancer. It refers to the campaign’s identified annual target population. State results range widely: six states reached 100%, while Assam reported 95.63%. The figures show the campaign’s reach, while the U-WIN platform supports real-time monitoring and beneficiary tracking.

03

Which girls can receive the free vaccine, and what consent is required?

The National HPV Vaccination Campaign offers a free, voluntary, single-dose HPV vaccine to girls who are 14 years old. The vaccine is available at government health facilities across the country. Parents or guardians must provide consent for a girl to receive it.

The age and consent rules define who the campaign is designed to reach and how vaccination takes place. The ministry says the girls are vaccinated before potential exposure to HPV, to maximise the vaccine’s preventive benefit. The campaign does not describe a multi-dose schedule; it specifies one dose.

The nationwide drive began in February 2026 and had administered more than 10 million doses in nine months, covering nearly 87% of the identified target cohort. Health workers, state and Union Territory governments, teachers, parents and local communities supported delivery. The U-WIN digital platform helps with real-time monitoring and beneficiary tracking across the campaign.

04

What is HPV, and how can some types of the virus lead to cervical cancer?

HPV stands for human papillomavirus. It is a group of related viruses, not a single virus. The article says HPV infections can cause cervical cancer, but it does not describe how that happens. This explanation adds established medical knowledge beyond the article’s details.

Some HPV types are considered high-risk because an infection that persists can cause changes in cells in the cervix. Over time, these abnormal changes may develop into cervical cancer. Most HPV infections do not become cancer, but preventing infection by cancer-causing types helps lower the risk of this outcome.

India’s campaign provides a single dose of HPV vaccine to 14-year-old girls, before potential exposure to the virus, with the aim of maximising preventive benefit. The ministry reported more than 10 million doses given in nine months and nearly 87% coverage of the identified target cohort. Cervical cancer is the second most common cancer among women in India after breast cancer.

05

Why does the campaign vaccinate girls at age 14, before they may be exposed to HPV?

The campaign vaccinates girls at age 14 because the ministry says this is before potential exposure to HPV. The goal is prevention: protection is intended to be in place before a person encounters the virus. HPV infections can cause cervical cancer, making early protection relevant to long-term health.

The campaign offers one free, voluntary dose at government health facilities, with parental consent. Its timing follows the preventive purpose described by the ministry: vaccinate adolescent girls before they may be exposed, rather than wait until later. The article does not give more detail on how age 14 was selected or on the vaccine’s biological action.

Launched in February 2026, the campaign had delivered more than 10 million doses in nine months, reaching nearly 87% of its identified target girls. The ministry says the drive was supported by governments, health workers, teachers, parents and local communities. Its U-WIN platform supports real-time monitoring and beneficiary tracking.

06

What long-term health outcome is the campaign designed to help prevent?

The long-term health outcome the campaign aims to help prevent is cervical cancer. The health ministry links the vaccine to protection against HPV infections that can cause the disease. Cervical cancer is a significant public health concern in India and is the second most common cancer among women in the country, after breast cancer.

The campaign offers a single dose to 14-year-old girls before potential exposure to HPV, with the intention of maximising preventive benefit. Vaccination is free and voluntary at government health facilities, and parental consent is required. The article presents the vaccine as prevention against HPV infections, not as a treatment for existing cervical cancer.

India launched the nationwide campaign in February 2026. In nine months, it administered more than 10 million doses, covering nearly 87% of its identified target cohort of about 12 million girls. The ministry says broad coordination and U-WIN tracking have helped expand and monitor access. The stated goal is to safeguard the health and well-being of future generations of women.

07

How does a vaccine prepare the immune system to recognize and fight an infection?

The article explains that the HPV vaccine helps protect recipients against HPV infections, but it does not describe how vaccines work. In general, a vaccine presents the immune system with a harmless form or piece of a germ, or instructions for making such a piece. This gives the body a way to learn what to recognise.

The immune system responds by making antibodies and activating other defences. It can also form memory cells. If the person later encounters the real infection, these defences may recognise it and respond faster, helping prevent illness or reduce its severity. The exact vaccine approach differs by vaccine; this is a general explanation, not a detail supplied in the article.

India’s campaign offers a single HPV vaccine dose to 14-year-old girls before potential exposure, aiming to maximise preventive benefit. More than 10 million doses were given in nine months, covering nearly 87% of the target cohort. The article does not state how long protection lasts or give details of the vaccine’s formulation.

This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.

Read more in the JupiteX app

Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.

Or read more news on the web